Literature DB >> 16231201

Design of ligand binding to an engineered protein cavity using virtual screening and thermal up-shift evaluation.

Claudia Machicado1, Jon López-Llano, Santiago Cuesta-López, Marta Bueno, Javier Sancho.   

Abstract

Proteins could be used to carry and deliver small compounds. As a tool for designing ligand binding sites in protein cores, a three-step virtual screening method is presented that has been optimised using existing data on T4 lysozyme complexes and tested in a newly engineered cavity in flavodoxin. The method can pinpoint, in large databases, ligands of specific protein cavities. In the first step, physico-chemical filters are used to screen the library and discard a majority of compounds. In the second step, a flexible, fast docking procedure is used to score and select a smaller number of compounds as potential binders. In the third step, a finer method is used to dock promising molecules of the hit list into the protein cavity, and an optimised free energy function allows discarding the few false positives by calculating the affinity of the modelled complexes. To demonstrate the portability of the method, several cavities have been designed and engineered in the flavodoxin from Anabaena PCC 7119, and the W66F/L44A double mutant has been selected as a suitable host protein. The NCI database has then been screened for potential binders, and the binding to the engineered cavity of five promising compounds and three tentative non-binders has been experimentally tested by thermal up-shift assays and spectroscopic titrations. The five tentative binders (some apolar and some polar), unlike the three tentative non-binders, are shown to bind to the host mutant and, importantly, not to bind to the wild type protein. The three-step virtual screening method developed can thus be used to identify ligands of buried protein cavities. We anticipate that the method could also be used, in a reverse manner, to identify natural or engineerable protein cavities for the hosting of ligands of interest.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16231201     DOI: 10.1007/s10822-005-7969-7

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  55 in total

Review 1.  Application of high-throughput screening techniques to drug discovery.

Authors:  B Cox; J C Denyer; A Binnie; M C Donnelly; B Evans; D V Green; J A Lewis; T H Mander; A T Merritt; M J Valler; S P Watson
Journal:  Prog Med Chem       Date:  2000

2.  Native hydrogen bonds in a molten globule: the apoflavodoxin thermal intermediate.

Authors:  M P Irún; M M Garcia-Mira; J M Sanchez-Ruiz; J Sancho
Journal:  J Mol Biol       Date:  2001-03-02       Impact factor: 5.469

3.  Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural product inhibitor, at 1.95 A resolution.

Authors:  F Pavão; M S Castilho; M T Pupo; R L A Dias; A G Correa; J B Fernandes; M F G F da Silva; J Mafezoli; P C Vieira; G Oliva
Journal:  FEBS Lett       Date:  2002-06-05       Impact factor: 4.124

4.  Discovery of novel low molecular weight inhibitors of IMPDH via virtual needle screening.

Authors:  Stephen D Pickett; Bradley S Sherborne; Trevor Wilkinson; James Bennett; Neera Borkakoti; Michael Broadhurst; David Hurst; Ian Kilford; Murray McKinnell; Philip S Jones
Journal:  Bioorg Med Chem Lett       Date:  2003-05-19       Impact factor: 2.823

5.  Structure of stable protein folding intermediates by equilibrium phi-analysis: the apoflavodoxin thermal intermediate.

Authors:  Luis A Campos; Marta Bueno; Jon Lopez-Llano; María Angeles Jiménez; Javier Sancho
Journal:  J Mol Biol       Date:  2004-11-12       Impact factor: 5.469

6.  Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide.

Authors:  S Iyer; D Kontoyiannis; D Chevrier; J Woo; N Mori; M Cornejo; G Kollias; R Buelow
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

7.  Specificity of ligand binding in a buried nonpolar cavity of T4 lysozyme: linkage of dynamics and structural plasticity.

Authors:  A Morton; B W Matthews
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

8.  Energetic origins of specificity of ligand binding in an interior nonpolar cavity of T4 lysozyme.

Authors:  A Morton; W A Baase; B W Matthews
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

9.  National Cancer Institute Drug Information System 3D database.

Authors:  G W Milne; M C Nicklaus; J S Driscoll; S Wang; D Zaharevitz
Journal:  J Chem Inf Comput Sci       Date:  1994 Sep-Oct

10.  The response of T4 lysozyme to large-to-small substitutions within the core and its relation to the hydrophobic effect.

Authors:  J Xu; W A Baase; E Baldwin; B W Matthews
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

View more
  1 in total

1.  Rescoring docking hit lists for model cavity sites: predictions and experimental testing.

Authors:  Alan P Graves; Devleena M Shivakumar; Sarah E Boyce; Matthew P Jacobson; David A Case; Brian K Shoichet
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.